As a clinical trial sponsor, the overall value and expertise that can be gained in outsourcing services for clinical studies is clear. However, many partnerships don’t last long because they fail to deliver study milestones and quality work.
Small to midsize companies usually have limited finances and a shorter timelines to run a clinical program vs. Big Pharma. Any delay resulting from a partner’s failure to deliver on time has a greater impact on smaller sponsors.
Watch this webinar to see why small to midsize companies should consider functional CROs to get through all phases of clinical trials. These CROs can be as impressive and deliver overall savings from both a financial and timeline perspective.
Complete this form to watch the “How Not to Be an ATM for Your CRO with Outsourcing Checks and Balances” webinar immediately.